Company Filing History:
Years Active: 2022
Title: Miriam Droste: Innovator in Cancer Treatment
Introduction
Miriam Droste is a prominent inventor based in Dietikon, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for cancer treatment.
Latest Patents
Miriam Droste holds a patent for "Binding members to PD-L1." This invention relates to anti-PD-L1 binding members, specifically monovalent, high potency PD-L1-binding antibody fragments that are highly stable and soluble. These binding members have potential applications in the treatment of cancer and inflammatory diseases, as well as in diagnostics. The patent also includes related nucleic acids, vectors, cells, and compositions.
Career Highlights
Throughout her career, Miriam has worked with notable companies such as Cell Medica Limited and Cell Medica Switzerland AG. Her work has focused on advancing therapeutic solutions that target critical pathways in cancer biology.
Collaborations
Miriam has collaborated with esteemed colleagues, including Abdijapar Shamshiev and Titus Kretzschmar, contributing to the advancement of innovative treatments in her field.
Conclusion
Miriam Droste's work exemplifies the impact of innovative thinking in biotechnology, particularly in the fight against cancer. Her contributions continue to pave the way for new therapeutic strategies and improved patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.